Phase II study of 131 I-MIBG with vincristine and 5 days of irinotecan for patients with relapsed or refractory neuroblastoma.

Journal of Clinical Oncology

Steven G. DuBois, M. Shelly Allen, Melissa Bent, Joan Hilton, Fabienne Hollinger, Jesse Courtier, Randall Hawkins, Yael P. Mosse, Katherine K. Matthay. Phase II study of 131 I-MIBG with vincristine and 5 days of irinotecan for patients with relapsed or refractory neuroblastoma. Journal of Clinical Oncology. 2014 May 20; 32(15_suppl):10033-10033.

2014
https://researcherprofiles.org/profile/79293089

Steven G. DuBois, M. Shelly Allen, Melissa Bent, Joan Hilton, Fabienne Hollinger, Jesse Courtier, Randall Hawkins, Yael P. Mosse, Katherine K. Matthay